Table: Taiko Pharmaceutical - 6-MTH group results

Taiko Pharmaceutical

10/08/2023 07:30

Aug 10 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.49                1.86             7.90     
                 (+34.0 pct)                          (+56.7 pct) 
  Operating     loss 396 mln          loss 2.42         532 mln   
  Recurring     loss 510 mln          loss 2.52         60 mln    
  Net                                                   50 mln    
  Net           loss 514 mln          loss 2.80                   
  EPS          loss 11.36 yen      loss 64.17 yen      1.15 yen   
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T